Review: Systemic sclerosis (scleroderma) in Remicade
This is a review of Systemic sclerosis (scleroderma) by studying 80,077 people who take Remicade. We analyze: the time on Remicade when people have Systemic sclerosis (scleroderma), gender and age of these people, the severity of Systemic sclerosis (scleroderma), how they recovered, and common conditions and drugs used besides Remicade. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 200 million drug outcomes from FDA and social media since 1977. The results are personalized to your gender and age. Start now >>>
Remicade (latest outcomes) has active ingredients of infliximab. It is often used in crohn's disease, rheumatoid arthritis. Commonly reported side effects of Remicade include infusion related reaction, fever, dyspnoea exacerbated, breathing difficulty, rashes.
Systemic sclerosis (scleroderma)
Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) has been reported by people with primary pulmonary hypertension, osteoporosis, rheumatoid arthritis, pulmonary hypertension, high blood pressure.
On Dec, 5, 2013: 80,077 people reported to have side effects when taking Remicade. Among them, 34 people (0.04%) have Systemic Sclerosis (scleroderma).
Time on Remicade when people have Systemic sclerosis (scleroderma) * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Systemic sclerosis (scleroderma)||42.86%||57.14%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have Systemic sclerosis (scleroderma) when taking Remicade * :
|Systemic sclerosis (scleroderma)||35.63%||64.37% |
Age of people who have Systemic sclerosis (scleroderma) when taking Remicade * :
|Systemic sclerosis (scleroderma)||0.00%||0.00%||0.00%||0.00%||4.48%||14.93%||14.93%||65.67% |
Severity of Systemic sclerosis (scleroderma) when taking Remicade ** :
How people recovered from Systemic sclerosis (scleroderma) ** :
Top conditions involved for these people * :
- Rheumatoid arthritis (34 people, 100.00%)
- Prophylaxis (34 people, 100.00%)
- Premedication (9 people, 26.47%)
- Ankylosing spondylitis (7 people, 20.59%)
- Crohn's disease (5 people, 14.71%)
Top co-used drugs for these people * :
- Rimatil (34 people, 100.00%)
- Unknown adrenal hormone preparations (34 people, 100.00%)
- Rheumatrex (34 people, 100.00%)
- Antihistamines (34 people, 100.00%)
- Gaster d (34 people, 100.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related search: Remicade, Systemic sclerosis (scleroderma)
You can also:
On eHealthMe, Remicade (infliximab) is often used for crohn's disease. Find out below the conditions Remicade is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Remicade used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Browse Remicade side effects from A to Z:
Browse Remicade drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Can you answer these questions (what is this?):
- By Vivitazy: Remicade or ulcerative colitis causing joint pain?
(for a 35 year old woman who has Ulcerative Colitis, and takes Remicade, Mesalamine, Purinethol)
Im also on mesalamine, 6 mp and trazadone. Ive had joint pain in elbow before but i realised it was caused by taking cortenema. I stoped the med and pain went away. After my first infusion of remicade (2days) i started with the knee, ankle, elbows , wrists and hands pain. The more i do. The worst ...
(Number of patients like Vivitazy: 569)
- By Kathy Fennimore: Did you experience hypoxia while taking cytoxan for iterstial lung disease related to scleroderma?
(for a 53 year old woman who has Scleroderma)
After second dose of IV Cytoxan I have experienced a blood oxygen level of 78-84 upon exertion of energy. This is being treated with 2L of nasal oxygen.
(Number of patients like Kathy Fennimore: 24)
- By Hope: I am experiencing myelodysplastic syndrome symptoms but it is said that it doesn't typically get diagnosed for people my age. although everything is spot on and i need to know whats wrong.
(for a 16 year old girl who has Crohns Disease, and takes Remicade)
I have been doing remicade treatments for about four years now. Lately I have gotten a UTI, an I get random bruises every single day, I also get super tired, my body aches, and I get fevers for hours on end without them breaking. I have no idea whats wrong because this has never happened before but ...
(Number of patients like Hope: 478)
More questions for: Remicade, Systemic sclerosis (scleroderma)
More reviews for: Remicade, Systemic sclerosis (scleroderma)
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.